MSD

Merck & Co., Inc., Rahway, New Jersey, USA is known as MSD outside of the United States and Canada.

A Legacy of Innovation

MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From MSD’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. We operate in more than 140 countries and had sales of more than $48 billion in 2022.

Partnering With MSD

We recognize that building partnerships is one of our most important jobs. In 2022, more than half of our human health revenue was attributable to acquisitions, alliance partnerships and patents and our team executed 97 significant business development transactions. We have BD professionals based in key innovation epicenters including Boston, San Francisco, London, Shanghai, Tokyo and our headquarters in Rahway, NJ.

We’re pursuing the most innovative areas in biomedical research emerging today without regard to therapeutic area or modality and working on collaborations from discovery to clinical-stage programs. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life.

Learn more at msdlicensing.com.